Hindustan Bio Sciences (BOM:532041) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Hindustan Bio Sciences's Free Cash Flow for the three months ended in Dec. 2023 was ₹0.00 Mil. Hindustan Bio Sciences's Revenue for the three months ended in Dec. 2023 was ₹3.22 Mil. Therefore, Hindustan Bio Sciences's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Hindustan Bio Sciences's current FCF Yield % is -0.57%.

The historical rank and industry rank for Hindustan Bio Sciences's FCF Margin % or its related term are showing as below:

BOM:532041' s FCF Margin % Range Over the Past 10 Years
Min: -82.95 Med: -18.43 Max: 74.9
Current: -5.42

During the past 13 years, the highest FCF Margin % of Hindustan Bio Sciences was 74.90%. The lowest was -82.95%. And the median was -18.43%.

BOM:532041's FCF Margin % is ranked worse than
63.27% of 1029 companies
in the Drug Manufacturers industry
Industry Median: 0.05 vs BOM:532041: -5.42

Hindustan Bio Sciences FCF Margin % Historical Data

The historical data trend for Hindustan Bio Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences FCF Margin % Chart

Hindustan Bio Sciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

-37.66

42.66

74.90

-82.95

-5.73

Hindustan Bio Sciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Hindustan Bio Sciences's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hindustan Bio Sciences's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's FCF Margin % falls into.

Hindustan Bio Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Hindustan Bio Sciences's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-0.498	/	8.692
	=	-5.73 %

Hindustan Bio Sciences's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	3.222
	=	0.00 %

Hindustan Bio Sciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hindustan Bio Sciences (BOM:532041) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034

Website

https://www.hindustanbiosciences.in

Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines